Market Overview

Endologix Disputes Alleged Patent Infringement

Endologix, Inc. (NASDAQ: ELGX) responded to the Bard Peripheral Vascular, Inc. lawsuit filed against Endologix in the United States District Court of Arizona. The Bard Peripheral lawsuit alleges that Endologix's proprietary high density ePTFE graft material, which is used for the Powerlink(R) System, infringes on Bard Peripheral's "Prosthetic Vascular Graft" patent.

Endologix, Inc. develops and manufactures minimally invasive treatments for aortic disorders.

Posted-In: News Markets

 

Most Popular

Related Articles (ELGX)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free

Benzinga Professional